News

Vinay Prasad, a top regulator at the US Food and Drug Administration, has left the agency after a controversy over his ...
Rare disease and gene therapy stocks, battered in recent months by clinical and commercial setbacks, will likely benefit from the sudden departure this past week of Vinayak (Vinay) Prasad, MD, as ...
It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...
Journal Editorial Report: Vinay Prasad exits after gene-therapy reversal. Why Britain faces a bigger Trump tariff blow ...
Vinay Prasad’s ouster as the Food and Drug Administration’s top vaccine and gene therapy regulator came after frustration ...
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
A top FDA appointee who doesn’t think patients can be trusted to make their own healthcare decisions.